Dr. Edith Perez on Immune Checkpoint Inhibition in Triple-Negative Breast Cancer OncLive 1:25 9 years ago 621 Скачать Далее
Dr. Perez on Immune Checkpoint Inhibition in Breast Cancer Targeted Oncology 1:26 9 years ago 131 Скачать Далее
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer OncLive 1:20 9 years ago 401 Скачать Далее
Dr. Edith Perez Discusses the Adjuvant Treatment of Breast Cancer OncLive 1:04 11 years ago 131 Скачать Далее
Dr. Edith Perez Discusses BOLERO-1 Trial Results for HER2-Positive Breast Cancer OncLive 1:07 9 years ago 203 Скачать Далее
Breast cancer: maximizing response to checkpoint inhibitors VJOncology 0:45 5 years ago 38 Скачать Далее
Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer ecancer 2:48 5 years ago 384 Скачать Далее
Dr. Edith Perez on the development of targeted therapies Breast Cancer Research Foundation 3:07 13 years ago 114 Скачать Далее
Checkpoint Inhibitors in the Neoadjuvant Treatment of Triple Negative Breast Cancer PracticeUpdate 4:19 4 years ago 41 Скачать Далее
The Significance of Tumor Infiltration Lymphocytes in Breast Cancer OncLive 7:41 9 years ago 1 993 Скачать Далее
Dr. Edith Perez Describes the Mayo Clinic Breast Cancer Translational Genomics Program OncLive 1:03 12 years ago 358 Скачать Далее
Dr. Edith Perez on her Anticipated Results for ASCO and SABCS OncLive 1:08 13 years ago 119 Скачать Далее
